FMD as a measure of endothelial function after six months of Effect of fluvastatin on endothelium-dependent brachial artery treatment. In contrast, FLU does not have a beneficial effect vasodilation in patients after renal transplantation. on brachial artery DC. Background. Hypercholesterolemia may affect both endothelial function and arterial distensibility (DC). Renal transplant recipients (NTX) exhibit advanced structural and functional alterations of arterial vessel walls. The aim of this double-Cardiovascular disease is a major cause of morbidity blind, randomized trial was to evaluate the effects of fluvastatin and mortality in patients after renal transplantation and (FLU) on brachial artery flow-mediated vasodilation (FMD) and DC in hypercholesterolemic NTX. one of the most important determinants of long-term out-Methods. Eighteen NTX received FLU 40 mg/day and 18 come of transplantation [1-3]. The functional and struc-NTX placebo (PLA). Before and after six months of treatment, tural alterations of large arteries leading to cardiovascuthe brachial artery diameter and DC at rest were measured by lar disease begin in the early stages of renal disease, and a Doppler frequency analysis in the M mode, and then changes in diameter during reactive hyperemia (to assess endothelial-by the time of renal transplantation, arterial disease is dependent FMD) and after 400 g sublingual nitroglycerin (to already advanced in the majority of even clinically assess endothelium-independent vasodilation-NMD).
arterial wall with eventually occlusion of the artery leadtween FLU-and PLA-treated patients and was not affected ing to ischemia and infarction [1] . Endothelial dysfuncby either treatment. Also, the brachial artery baseline diameter tion and disturbed cushioning function of large arteries was not different between groups and was not affected by are generally observed after renal transplantation [5], FLU or PLA. Brachial artery flow at rest and during reactive but are also found in patients without clinical symptoms hyperemia as measured by pulsed Doppler did not differ between groups. Brachial artery FMD increased with FLU from of cardiovascular disease and are associated with sub-0.23 Ϯ 0.08 to 0.54 Ϯ 0.08 mm (P Ͻ 0.05), whereas PLA did stantial structural vessel wall alterations such as intima not alter FMD (0.22 Ϯ 0.07 vs. 0.14 Ϯ 0.05 mm at baseline media thickening and atherosclerotic plaque formation and after six months of PLA treatment, respectively, P ϭ NS).
[4]. Hypercholesterolemia is observed in the majority of In contrast, NMD did not change significantly with either treatpatients after renal transplantation [6] and may be a mament (0.76 Ϯ 0.13 vs. 0.83 Ϯ 0.15 mm at baseline and after 6 months of FLU treatment, respectively, P ϭ NS, and 0.64 Ϯ jor contributor to the previously mentioned vessel wall 0.09 vs. 0.66 Ϯ 0.10 mm at baseline and after 6 months of PLA alterations [7] . In hypercholesterolemic humans withtreatment, respectively, P ϭ NS). Also, brachial artery DC was out cardiovascular disease, endothelial dysfunction is not altered by FLU (6.4 Ϯ 1.0 vs. 5.8 Ϯ 0.6 ϫ 10 Ϫ3 /kPa, P ϭ improved by treatment with 3-hydroxy-3-methylglutaryl and after renal transplantation. The present study was with dinner. Patients were studied twice: at entry into the study and after the six-month observation period. therefore designed to test the hypothesis that the HMG-CoA reductase inhibitor fluvastatin (FLU) can improve Measurements endothelial function and arterial distensibility in patients after renal transplantation. In the present prospective, All studies were performed between 8 and 12 a.m. double-blind, randomized study, flow-mediated vasodila-Twelve to 14 hours had elapsed between the measuretion (FMD) and distensibility of the brachial artery were ments and previous intake of cyclosporine or antihypermeasured by high-resolution ultrasound and Doppler fretensive drugs. Only patients without an arteriovenous quency analysis of vessel wall movements in M mode as fistula or previous vascular surgery on the right arm indices of endothelial function and mechanical vessel were included into study. Following blood sampling and wall properties, respectively, in placebo and FLU-treated routine clinical examination, blood pressure, distensirenal transplant recipients.
bility (DC), as well as flow-mediated and nitroglycerinmediated vasodilation of the brachial artery were studied as described earlier [5] , after a rest of at least 15 minutes METHODS in a supine position. In brief, brachial artery blood pres-We performed a randomized, prospective, double-blind, sure was measured using an automatic sphygmomanomplacebo-controlled trial that was approved by the ethics eter, and heart rate was determined using an echocardiocommittee of the University of Mü nster School of Medigram monitor. After blood pressure measurements, the cine. All patients gave their written informed consent.
brachial artery of the right arm was visualized in a longi-Eligible patients were between 18 and 60 years of age tudinal section 2 to 6 cm above the elbow using a 7.5 MHz and had received a kidney from a cadaveric donor at linear array transducer and a standard Toshiba ultraleast six months earlier. At the time of transplantation, sound system. The brachial artery was displayed in B all patients had been instructed to follow a reduced choand M modes. Vessel diameter was then analyzed using lesterol (American Heart Association step 1 diet). Renal a multigate pulsed Doppler system. Low-frequency Dopptransplant function was stable, and the serum creatinine ler signals originating from the sample volumes coincidlevel was below 2.5 mg/dL in all patients at entry into study.
ing with the arterior and posterior vessel walls were Patients with serum cholesterol levels above 200 mg/dL processed. The positions of sample volumes were continand below 350 mg/dL were included into study. Subjects uously adjusted according to the displacement of the with prior HMG-CoA reductase inhibitor or other antiwall. Using the echocardiogram trigger, the end-diastolic lipidemic medication were excluded. Blood pressure was diameter and distention (diastolic-systolic diameter controlled in hypertensive renal transplant recipients by change) of the brachial artery were measured. Coeffiantihypertensive drugs, and blood pressure levels were cient of variation was 4.5% for the end-diastolic diameter below 160 mm Hg systolic and 90 mm Hg diastolic in (N ϭ 26) and 9.6 Ϯ 1.6% (N ϭ 26) for the relative all patients at randomization. Patients with clinical evidistention of the brachial artery. After two measuredence of cardiovascular disease or diabetes mellitus were ments of end-diastolic diameter at baseline were taken, excluded. An immunosuppressive drug regimen with a cuff placed on the forearm was inflated at 300 mm Hg cyclosporine A and prednisolone (5 to 10 mg/day) was during four minutes. During the last minute of cuff inflaused. Cyclosporine whole-blood trough concentrations tion and at 1, 3, 5, 7, and 10 minutes after cuff release, (measured by high-performance liquid chromatography) further measurements of brachial end-diastolic diameter were maintained at 75 to 150 g/L by dose adjustment.
were taken. Brachial artery flow at baseline and during A total of 40 patients was included into the study.
the initial 15 seconds of reactive hyperemia was estimated using a pulsed Doppler. Eleven minutes after cuff Causes of renal failure were chronic glomerulonephrirelease and return of the brachial artery diameter to tis in 21 cases, chronic interstitial nephritis in 7 cases, baseline values, 400 g of glycerol trinitrate were adminglomerulosclerosis in 2 cases, polycystic renal disease in istered sublingually, and further scans of the brachial 4 cases, hydronephrosis in 1 case, Alport's disease in artery were taken after one, three, and five minutes. 1 case, and unknown in 4 cases. Antihypertensive ther-Ultrasound measurements were taken by two investigaapy consisted of ␤ blockers (21 patients), calcium antagotors (M.H. and M.B.); however, in each patient, both nists (25 patients), angiotensin-converting enzyme (ACE) measurements were taken by the same investigator. inhibitors (19 patients), ␣ blockers (4 patients), and loop diuretics (21 patients). Antihypertensive treatment was Analyses not changed in any patient during the six-month observation period.
From the end-diastolic diameter (d), the relative systolic increase of vessel diameter (relative distention ϭ Patients were randomly assigned to six months of treatment with FLU 40 mg or matching PLA taken once daily ⌬d ϫ d Ϫ1 ) and from the SBP and diastolic blood pressure between both study groups, and therapy with either FLU or PLA did not significantly alter triglyceride levels.
The results of blood pressure measurements and the (DBP), arterial wall DC was calculated (DC coefficient vessel parameters are shown in Table 3 and
and 2. Blood pressure at baseline was not significantly Flow-mediated vasodilation was calculated as the maxdifferent between FLU-and PLA-treated patients and remained unchanged after six months of therapy. The imum increase in brachial artery end-diastolic diameter same was true for pulse pressure and heart rate. during reactive hyperemia. Nitroglycerine-mediated va-
The end-diastolic diameter of the brachial artery at sodilation was accordingly calculated as the maximum baseline was not significantly different in FLU-treated increase in brachial artery end-diastolic diameter after patients when compared with PLA-treated patients. sublingual glycerol trinitrate.
There was no significant effect of either treatment on Data were expressed as mean Ϯ SEM. A statistical end-diastolic diameter of the brachial artery. Brachial comparison between the FLU-treated and PLA-treated artery distention and DC coefficients were also comparagroups was carried out using the Student t test for continble in both study groups at baseline and not significantly uous variables and the chi-square test for qualitative influenced by either treatment. variables. To test the effects of a sixth-month therapy Flow-mediated vasodilation at baseline was similar in with FLU or PLA, repeated measures of analysis of variboth study groups. However, FMD of the brachial artery ance with adjustment for covariates (ANCOVA) was used. significantly improved after six months of treatment with Within-and between-group comparisons were made FLU. In contrast, FMD of the brachial artery did not with post hoc tests (planned contrasts).
change from baseline values after six months of PLA therapy. Improved FMD in FLU-treated patients was not RESULTS related to changes in brachial artery blood flow. Resting brachial blood flow at baseline and after six months of Four of the 40 included patients dropped out during therapy was not different between both study groups. follow-up, and a second measurement of vessel wall prop-Peak blood flow after release of forearm occlusion was erties could not be obtained. One patient (PLA group) also comparable between both study groups at baseline developed bronchial carcinoma. One patient (FLU group) and after six months of therapy. The effect of FLU as comdeveloped myalgias, and two patients (one in each pared with PLA on brachial artery FMD also remained group) withdrew consent. The following analysis, therestatistically significant after adjustment for brachial arfore, is confined to the remaining 36 patients available tery diameter (P Ͻ 0.05) as analyzed by ANCOVA. for according-to-protocol analysis.
Endothelium-independent nitroglycerin-induced vaso-Baseline characteristics of the two groups are shown dilation was similar in FLU-treated and in PLA-treated in Table 1 . There were no significant differences between patients at baseline and after six months of therapy. FLU-and PLA-treated patients with respect to age, time Changes in brachial artery flow-mediated dilatation after transplantation, number of smokers, gender, and were not related to changes in serum cholesterol levels body mass index.
in either group (Fig. 3) and were also not related to Biochemical parameters at entry and after six months changes in LDL cholesterol levels after FLU or PLA of therapy are shown in Table 2 . Cyclosporine and serum treatment (r ϭ 0.29 for the FLU group and r ϭ 0.16 for creatinine levels at entry and after six months were comthe PLA group, both P ϭ NS). parable in the FLU-and the PLA-treated groups ( Table 2) . The same was true for glucose, bilirubin levels, and cre-DISCUSSION atine kinase activity. Total serum cholesterol and lowdensity lipoprotein (LDL) cholesterol levels at entry were The present randomized, double-blind, PLA-controlled study shows that six months of therapy with the HMG-not significantly different in the group treated with FLU reductase inhibitor in patients with end-stage renal disease. Since there is a close correlation between endothelial-mediated vasodilation of peripheral and coronary arteries [16] , our finding of improved endothelial-mediated brachial artery vasodilation in renal transplant patients suggests a beneficial effect of FLU treatment on the excess cardiovascular morbidity and mortality in this patient group [3] . Prospective studies investigating this issue are in progress (for example, ALERT study), however, results are not available yet.
The observed improvement of endothelial function in renal transplant patients with FLU could also relate to improved graft survival [17] . Katznelson and Kobashigawa observed a decreased incidence of acute rejections in renal transplant patients treated with pravastatin, which was accompanied by an inhibition of cytotoxic killer cell activity [18] . It has recently been shown that FLU inhibits the expression of adhesion molecules in human monocyte cell lines [19] , which may be of importance for both immunologic processes in allograft rejection and progression of atherosclerotic lesions. We did transplantation who had excellent graft function and by the relatively short observation period.
We did not observe a correlation between the reduction in serum total cholesterol or LDL cholesterol con-CoA reductase inhibitor FLU can significantly improve centrations and the achieved increase in brachial artery endothelial function in patients after renal transplantaflow-mediated dilation. This could indicate a cholesteroltion. FMD of the brachial artery significantly improved independent effect of FLU on endothelial function in with FLU when compared with PLA treatment. The data renal transplant recipients [15] . In patients with coronary of the present study therefore suggest that endothelial artery disease, Jarvisalo et al found brachial artery flowdysfunction is reversible in patients after renal transmediated dilation to be significantly better in patients plantation despite substantial structural wall alterations on HMG-CoA reductase inhibitor medication than in of large arteries, which often are found in these patients patients without HMG-CoA reductase inhibitor therapy, even in the absence of clinical evidence of cardiovascular despite similar cholesterol levels. The effect on FMD disease [4] . In contrast, FLU failed to improve mechaniwas dose dependent [11] . This could be explained by the cal wall properties of the brachial artery in renal transobservation of Laufs et al, who reported a direct up-regplant patients.
ulation of endothelial nitric oxide synthase by HMG-CoA Several studies have shown convincingly that already reductase inhibitors [20] . Recently, the cellular uptake short-term HMG-CoA reductase inhibitor therapy can mechanism for FLU in endothelial cells of the human improve endothelial dysfunction in patients with hyperaorta could be characterized suggesting that also FLU cholesterolemia free of cardiovascular disease or diabemay have a direct effect on the expression of endothelial tes mellitus. This has been shown for the forearm vascunitric oxide synthase [21] . lar bed [8, 9] as well as for the coronary vessels [13] . Also, Recent observations suggest that an altered expression in patients with coronary artery disease, recent observaof angiotensin II type 1 (AT 1 ) receptors may contribute tions indicate an improvement of endothelial dependent to the improved endothelial function with statin therapy vasodilation by HMG-CoA reductase inhibitors [11, 14] . [22] . In the present study, patients receiving FLU and Improvement of endothelial dysfunction is suggested to patients receiving PLA did not differ significantly in their be a major factor that explains the success of HMGantihypertensivie medication, particularly not in angio-CoA reductase inhibitors in the primary and secondary tensin-converting enzyme inhibitor use. Antihypertenprevention of cardiovascular disease [15] . To our knowlsive medication was not changed in any of the patients edge, the current study is the first report of improvement during the six months of follow-up. It has been shown that apart from its effects on endo-of endothelial dependent vasodilation by an HMG-CoA thelial function hypercholesterolemia also affects me-this is the first report demonstrating improved endothelial function with HMG-CoA reductase inhibitor treat-chanical vessel wall properties of large [23] and mediumsized arteries [24] . In contrast to the beneficial effects ment in end-stage renal disease. This is an important finding since renal allograft recipients even without clinical of FLU on brachial artery FMD, we did not observe an improvement of brachial artery distensibility with FLU. evidence of cardiovascular disease already exhibit substantial structural alterations of large arteries, which differ It has to be noted that fewer atherosclerotic lesions are found in the brachial artery than in large elastic-type from those observed in patients with hypercholesterolemia [1], and this finding may be of prognostic relevance. arteries [25, 26] and that brachial artery elastic wall properties are largely determined by blood pressure [27] .
In contrast, FLU did not improve elastic properties of the brachial artery in renal allograft recipients. Therefore, FLU treatment could have resulted in improved DC of elastic type arteries, for example, the common carotid artery, which is prone to atherosclerosis ACKNOWLEDGMENTS and in which the elastic properties are influenced by 
